Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target.


Journal

Memorias do Instituto Oswaldo Cruz
ISSN: 1678-8060
Titre abrégé: Mem Inst Oswaldo Cruz
Pays: Brazil
ID NLM: 7502619

Informations de publication

Date de publication:
2022
Historique:
received: 17 12 2021
accepted: 31 01 2022
entrez: 30 3 2022
pubmed: 31 3 2022
medline: 1 4 2022
Statut: epublish

Résumé

Over the past years, natural products have been explored in order to find biological active substances to treat various diseases. Regarding their potential action against parasites such as trypanosomatids, specially Trypanosoma cruzi and Leishmania spp., much advance has been achieved. Extracts and purified molecules of several species from genera Piper, Tanacetum, Porophyllum, and Copaifera have been widely investigated by our research group and exhibited interesting antitrypanosomal and antileishmanial activities. These natural compounds affected different structures in parasites, and we believe that the mitochondrion is a strategic target to induce parasite death. Considering that these trypanosomatids have a unique mitochondrion, this cellular target has been extensively studied aiming to find more selective drugs, since the current treatment of these neglected tropical diseases has some challenges such as high toxicity and prolonged treatment time. Here, we summarise some results obtained with natural products from our research group and we further highlighted some strategies that must be considered to finally develop an effective chemotherapeutic agent against these parasites.

Identifiants

pubmed: 35352776
pii: S0074-02762022000100861
doi: 10.1590/0074-02760220396
pmc: PMC8970591
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e220396

Références

Biomed Res Int. 2014;2014:614014
pubmed: 24800243
Front Microbiol. 2012 Aug 06;3:283
pubmed: 22888328
Biochim Biophys Acta. 2008 Nov;1780(11):1236-48
pubmed: 18395526
Exp Parasitol. 2011 Oct;129(2):145-51
pubmed: 21771592
Semin Cell Dev Biol. 2001 Dec;12(6):449-57
pubmed: 11735379
Nat Prod Rep. 2007 Apr;24(2):278-97
pubmed: 17389998
Biol Pharm Bull. 2006 Oct;29(10):2126-30
pubmed: 17015964
Antimicrob Agents Chemother. 2015 Nov 23;60(2):890-903
pubmed: 26596953
Nat Prod Rep. 2011 Apr;28(4):809-23
pubmed: 21290079
Expert Opin Drug Discov. 2019 Nov;14(11):1161-1174
pubmed: 31411084
Evid Based Complement Alternat Med. 2013;2013:940531
pubmed: 23573160
Phytomedicine. 2010 Dec 15;18(1):36-9
pubmed: 21035317
Subcell Biochem. 2014;74:1-42
pubmed: 24264239
Curr Pharm Biotechnol. 2009 Jan;10(1):106-21
pubmed: 19149593
Nat Prod Rep. 2009 Nov;26(11):1488-503
pubmed: 19844642
Antimicrob Agents Chemother. 2005 Jan;49(1):176-82
pubmed: 15616293
Planta Med. 2013 Mar;79(5):330-3
pubmed: 23457021
Mem Inst Oswaldo Cruz. 2009 Jul;104(4):549-54
pubmed: 19722074
Nat Prod Rep. 2010 Feb;27(2):238-54
pubmed: 20111803
Mem Inst Oswaldo Cruz. 2013 Feb;108(1):59-64
pubmed: 23440116
Phytomedicine. 2012 Dec 15;20(1):59-66
pubmed: 23069248
Free Radic Biol Med. 2013 Jul;60:17-28
pubmed: 23376033
Curr Biol. 2014 May 19;24(10):R453-62
pubmed: 24845678
Physiol Rev. 1979 Jul;59(3):527-605
pubmed: 37532
J Med Chem. 2012 Apr 12;55(7):2994-3001
pubmed: 22440015
Mol Biochem Parasitol. 2016 Mar-Apr;206(1-2):67-74
pubmed: 26592324
Parasitol Res. 2006 Dec;100(1):31-7
pubmed: 16783543
Neurochem Res. 2003 Oct;28(10):1575-81
pubmed: 14570403
Evid Based Complement Alternat Med. 2012;2012:898419
pubmed: 21716677
Microbes Infect. 2011 Nov;13(12-13):1018-24
pubmed: 21683800
Exp Parasitol. 2008 Mar;118(3):324-30
pubmed: 17950283
Photodiagnosis Photodyn Ther. 2017 Sep;19:256-265
pubmed: 28587855
Planta Med. 2013 Jul;79(11):952-8
pubmed: 23824551
Chem Biodivers. 2013 Jul;10(7):1350-60
pubmed: 23847080
Biomed Res Int. 2015;2015:815023
pubmed: 26078965
J Struct Biol. 2005 Apr;150(1):11-22
pubmed: 15797726
Clin Microbiol Rev. 1999 Oct;12(4):564-82
pubmed: 10515903
Mol Biochem Parasitol. 2001 Jul;115(2):189-98
pubmed: 11420105
Nat Prod Rep. 2010 Feb;27(2):165-237
pubmed: 20111802
Pharm Res. 2011 Nov;28(11):2758-70
pubmed: 21935742
J Ethnopharmacol. 2008 Nov 20;120(2):204-8
pubmed: 18775772
PLoS Negl Trop Dis. 2013 May 09;7(5):e2213
pubmed: 23675545
Parasitol Int. 2010 Jun;59(2):154-8
pubmed: 20064628
Molecules. 2011 Apr 26;16(5):3469-78
pubmed: 21522080
Nat Prod Rep. 2009 Oct;26(10):1321-44
pubmed: 19779642
Nat Prod Rep. 2004 Jun;21(3):353-64
pubmed: 15162223
Nat Prod Rep. 2009 Dec;26(12):1535-54
pubmed: 19936385

Auteurs

Danielle Lazarin-Bidóia (D)

Universidade Estadual de Maringá, Laboratório de Inovação Tecnológica no Desenvolvimento de Fármacos e Cosméticos, Maringá, PR, Brasil.

Francielle Pelegrin Garcia (FP)

Universidade Estadual de Maringá, Laboratório de Inovação Tecnológica no Desenvolvimento de Fármacos e Cosméticos, Maringá, PR, Brasil.

Tânia Ueda-Nakamura (T)

Universidade Estadual de Maringá, Laboratório de Inovação Tecnológica no Desenvolvimento de Fármacos e Cosméticos, Maringá, PR, Brasil.

Sueli de Oliveira Silva (SO)

Universidade Estadual de Maringá, Laboratório de Inovação Tecnológica no Desenvolvimento de Fármacos e Cosméticos, Maringá, PR, Brasil.

Celso Vataru Nakamura (CV)

Universidade Estadual de Maringá, Laboratório de Inovação Tecnológica no Desenvolvimento de Fármacos e Cosméticos, Maringá, PR, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH